I've addressed this issue before, too, @adreamer.
It seems today's theme is "Hits and memories". Tiresome.
The point you've raised is correct - they were actually inelligible to apply because they did not possess sufficient cGMP drug for a trial.
There's also the small issue of no/inadequate PK data and an undefined MOA.
The WEHI, 360 Biolabs and Leiden data is all 'promising' but inadequate as the basis for a human clinical trial.
Once we have the safety and PK from the GRANT FUNDED MND TRIAL, we'll be in a much better position to progress with human clinical trials in other indications. Like, for instance, COVID-19 and human cancers.
Wait a minute.... I've heard this somewhere before.
Cheers
Densy
- Forums
- ASX - By Stock
- PAA
- Ann: Canine Cancer Trial Update
Ann: Canine Cancer Trial Update, page-70
-
- There are more pages in this discussion • 151 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
21.0¢ |
Change
-0.005(2.33%) |
Mkt cap ! $93.45M |
Open | High | Low | Value | Volume |
21.0¢ | 21.5¢ | 21.0¢ | $85.73K | 407.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 53482 | 21.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.5¢ | 278844 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 53482 | 0.210 |
4 | 139384 | 0.205 |
8 | 455445 | 0.200 |
9 | 277593 | 0.195 |
10 | 713952 | 0.190 |
Price($) | Vol. | No. |
---|---|---|
0.215 | 137179 | 3 |
0.220 | 330867 | 10 |
0.225 | 144118 | 3 |
0.230 | 113191 | 3 |
0.240 | 32634 | 2 |
Last trade - 15.15pm 19/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |